Global and India Vaccine Adjuvants Market Report & Forecast 2023-2029

and India Vaccine Adjuvants Market

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

In India, the Vaccine Adjuvants revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.

This report focuses on global and India Vaccine Adjuvants market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Vaccine Adjuvants will continue to grow rapidly in the future.

Global Vaccine Adjuvants Scope and Market Size

Vaccine Adjuvants market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Vaccine Adjuvants market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Vaccine Adjuvants Market Report

1.1 Vaccine Adjuvants Product Introduction

1.2 Global Vaccine Adjuvants Outlook 2018 VS 2022 VS 2029

1.2.1 Global Vaccine Adjuvants Sales in US$ Million for the Year 2018-2029

1.2.2 Global Vaccine Adjuvants Sales in Volume for the Year 2018-2029

1.3 India Vaccine Adjuvants Outlook 2018 VS 2022 VS 2029

1.3.1 India Vaccine Adjuvants Sales in US$ Million for the Year 2018-2029

1.3.2 India Vaccine Adjuvants Sales in Volume for the Year 2018-2029

1.4 Vaccine Adjuvants Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Vaccine Adjuvants in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Vaccine Adjuvants Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Vaccine Adjuvants Market Dynamics

1.5.1 Vaccine Adjuvants Industry Trends

1.5.2 Vaccine Adjuvants Market Drivers

1.5.3 Vaccine Adjuvants Market Challenges

1.5.4 Vaccine Adjuvants Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2.1 Vaccine Adjuvants Market Segment by Type

2.1.1 Aluminum Adjuvant

2.1.2 Emulsions Adjuvant

2.1.3 Others

2.2 Global Vaccine Adjuvants Market Size by Type

2.2.1 Global Vaccine Adjuvants Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Vaccine Adjuvants Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Vaccine Adjuvants Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Vaccine Adjuvants Market Size by Type

2.3.1 India Vaccine Adjuvants Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Vaccine Adjuvants Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Vaccine Adjuvants Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3.1 Vaccine Adjuvants Market Segment by Application

3.1.1 Human Vaccine

3.1.2 Veterinary Vaccine

3.2 Global Vaccine Adjuvants Market Size by Application

3.2.1 Global Vaccine Adjuvants Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Vaccine Adjuvants Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Vaccine Adjuvants Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Vaccine Adjuvants Market Size by Application

3.3.1 India Vaccine Adjuvants Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Vaccine Adjuvants Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Vaccine Adjuvants Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4.1 Global Vaccine Adjuvants Market Size by Company

4.1.1 Global Key Manufacturers of Vaccine Adjuvants, Ranked by Revenue (2022)

4.1.2 Global Vaccine Adjuvants Revenue by Manufacturer (2018-2023)

4.1.3 Global Vaccine Adjuvants Sales by Manufacturer (2018-2023)

4.1.4 Global Vaccine Adjuvants Price by Manufacturer (2018-2023)

4.2 Global Vaccine Adjuvants Concentration Ratio (CR)

4.2.1 Vaccine Adjuvants Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Vaccine Adjuvants in 2022

4.2.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Vaccine Adjuvants, Product Offered and Application

4.5 Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Vaccine Adjuvants Market Size by Company

4.7.1 Key Players of Vaccine Adjuvants in India, Ranked by Revenue (2022)

4.7.2 India Vaccine Adjuvants Revenue by Players (2018-2023)

4.7.3 India Vaccine Adjuvants Sales by Players (2018-2023)

5.1 Global Vaccine Adjuvants Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Vaccine Adjuvants Market Size in Volume by Region (2018-2029)

5.2.1 Global Vaccine Adjuvants Sales in Volume by Region: 2018-2023

5.2.2 Global Vaccine Adjuvants Sales in Volume Forecast by Region (2024-2029)

5.3 Global Vaccine Adjuvants Market Size in Value by Region (2018-2029)

5.3.1 Global Vaccine Adjuvants Sales in Value by Region: 2018-2023

5.3.2 Global Vaccine Adjuvants Sales in Value by Region: 2024-2029

6.1 Americas Vaccine Adjuvants Market Size YoY Growth 2018-2029

6.2 Americas Vaccine Adjuvants Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Vaccine Adjuvants Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Vaccine Adjuvants Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Vaccine Adjuvants Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Vaccine Adjuvants Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7.1 EMEA Vaccine Adjuvants Market Size YoY Growth 2018-2029

7.2 EMEA Vaccine Adjuvants Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Vaccine Adjuvants Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Vaccine Adjuvants Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Vaccine Adjuvants Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Vaccine Adjuvants Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8.1 China Vaccine Adjuvants Market Size YoY Growth 2018-2029

8.2 China Vaccine Adjuvants Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Vaccine Adjuvants Sales in Volume, by Application (2018, 2022 & 2029)

9.1 APAC Vaccine Adjuvants Market Size YoY Growth 2018-2029

9.2 APAC Vaccine Adjuvants Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Vaccine Adjuvants Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Vaccine Adjuvants Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Vaccine Adjuvants Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Vaccine Adjuvants Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10.1 GSK

10.1.1 GSK Company Information

10.1.2 GSK Description and Business Overview

10.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.1.4 GSK Vaccine Adjuvants Products Offered

10.1.5 GSK Recent Development

10.2 CSL Limited

10.2.1 CSL Limited Company Information

10.2.2 CSL Limited Description and Business Overview

10.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.2.4 CSL Limited Vaccine Adjuvants Products Offered

10.2.5 CSL Limited Recent Development

10.3 Croda

10.3.1 Croda Company Information

10.3.2 Croda Description and Business Overview

10.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Croda Vaccine Adjuvants Products Offered

10.3.5 Croda Recent Development

10.4 SEPPIC

10.4.1 SEPPIC Company Information

10.4.2 SEPPIC Description and Business Overview

10.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.4.4 SEPPIC Vaccine Adjuvants Products Offered

10.4.5 SEPPIC Recent Development

10.5 Novavax

10.5.1 Novavax Company Information

10.5.2 Novavax Description and Business Overview

10.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Novavax Vaccine Adjuvants Products Offered

10.5.5 Novavax Recent Development

10.6 SPI Pharma

10.6.1 SPI Pharma Company Information

10.6.2 SPI Pharma Description and Business Overview

10.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.6.4 SPI Pharma Vaccine Adjuvants Products Offered

10.6.5 SPI Pharma Recent Development

10.7 Phibro

10.7.1 Phibro Company Information

10.7.2 Phibro Description and Business Overview

10.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Phibro Vaccine Adjuvants Products Offered

10.7.5 Phibro Recent Development

10.8 SDA BIO

10.8.1 SDA BIO Company Information

10.8.2 SDA BIO Description and Business Overview

10.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.8.4 SDA BIO Vaccine Adjuvants Products Offered

10.8.5 SDA BIO Recent Development

10.9 Invivogen

10.9.1 Invivogen Company Information

10.9.2 Invivogen Description and Business Overview

10.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Invivogen Vaccine Adjuvants Products Offered

10.9.5 Invivogen Recent Development

10.10 Tj Kaiwei

10.10.1 Tj Kaiwei Company Information

10.10.2 Tj Kaiwei Description and Business Overview

10.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Tj Kaiwei Vaccine Adjuvants Products Offered

10.10.5 Tj Kaiwei Recent Development

10.11 OZ Biosciences

10.11.1 OZ Biosciences Company Information

10.11.2 OZ Biosciences Description and Business Overview

10.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.11.4 OZ Biosciences Vaccine Adjuvants Products Offered

10.11.5 OZ Biosciences Recent Development

10.12 Brenntag Biosector

10.12.1 Brenntag Biosector Company Information

10.12.2 Brenntag Biosector Description and Business Overview

10.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.12.4 Brenntag Biosector Vaccine Adjuvants Products Offered

10.12.5 Brenntag Biosector Recent Development

10.13 MVP Laboratories

10.13.1 MVP Laboratories Company Information

10.13.2 MVP Laboratories Description and Business Overview

10.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.13.4 MVP Laboratories Vaccine Adjuvants Products Offered

10.13.5 MVP Laboratories Recent Development

10.14 Zhuoyue

10.14.1 Zhuoyue Company Information

10.14.2 Zhuoyue Description and Business Overview

10.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.14.4 Zhuoyue Vaccine Adjuvants Products Offered

10.14.5 Zhuoyue Recent Development

10.15 Aphios

10.15.1 Aphios Company Information

10.15.2 Aphios Description and Business Overview

10.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)

10.15.4 Aphios Vaccine Adjuvants Products Offered

10.15.5 Aphios Recent Development

11.1 Vaccine Adjuvants Industry Chain Analysis

11.2 Vaccine Adjuvants Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Vaccine Adjuvants Production Mode & Process

11.4 Vaccine Adjuvants Sales and Marketing

11.4.1 Vaccine Adjuvants Sales Channels

11.4.2 Vaccine Adjuvants Distributors

11.5 Vaccine Adjuvants Customers

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Vaccine Adjuvants CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

    Table 2. Vaccine Adjuvants Market Trends

    Table 3. Vaccine Adjuvants Market Drivers

    Table 4. Vaccine Adjuvants Market Challenges

    Table 5. Vaccine Adjuvants Market Restraints

    Table 6. Global Vaccine Adjuvants Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

    Table 7. India Vaccine Adjuvants Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

    Table 8. Global Vaccine Adjuvants Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

    Table 9. India Vaccine Adjuvants Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

    Table 10. Global Key Manufacturers of Vaccine Adjuvants, Ranked by Revenue (2022) & (US$ Million)

    Table 11. Global Vaccine Adjuvants Revenue by Manufacturer, (US$ Million), 2018-2023

    Table 12. Global Vaccine Adjuvants Revenue Share by Manufacturer, 2018-2023

    Table 13. Global Vaccine Adjuvants Sales by Manufacturer, (MT), 2018-2023

    Table 14. Global Vaccine Adjuvants Sales Share by Manufacturer, 2018-2023

    Table 15. Global Vaccine Adjuvants Price by Manufacturer (2018-2023) & (USD/Kg)

    Table 16. Global Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 17. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2022)

    Table 18. Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Base Distribution and Headquarters

    Table 19. Global Key Manufacturers of Vaccine Adjuvants, Product Offered and Application

    Table 20. Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry

    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 22. Key Players of Vaccine Adjuvants in India, Ranked by Revenue (2022) & (US$ million)

    Table 23. India Vaccine Adjuvants Revenue by Players, (US$ Million), (2018-2023)

    Table 24. India Vaccine Adjuvants Revenue Share by Players, (2018-2023)

    Table 25. India Vaccine Adjuvants Sales by Players, (MT), (2018-2023)

    Table 26. India Vaccine Adjuvants Sales Share by Players, (2018-2023)

    Table 27. Global Vaccine Adjuvants Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 28. Global Vaccine Adjuvants Sales in Volume by Region (2018-2023) & (MT)

    Table 29. Global Vaccine Adjuvants Sales in Volume Forecast by Region (2024-2029) & (MT)

    Table 30. Global Vaccine Adjuvants Sales in Value by Region (2018-2023) & (US$ Million)

    Table 31. Global Vaccine Adjuvants Sales in Value Forecast by Region (2024-2029) & (US$ Million)

    Table 32. Americas Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. Americas Vaccine Adjuvants Sales in Value by Country (2018-2023) & (US$ Million)

    Table 34. Americas Vaccine Adjuvants Sales in Value by Country (2024-2029) & (US$ Million)

    Table 35. Americas Vaccine Adjuvants Sales in Volume by Country (2018-2023) & (MT)

    Table 36. Americas Vaccine Adjuvants Sales in Volume by Country (2024-2029) & (MT)

    Table 37. EMEA Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. EMEA Vaccine Adjuvants Sales in Value by Country (2018-2023) & (US$ Million)

    Table 39. EMEA Vaccine Adjuvants Sales in Value by Country (2024-2029) & (US$ Million)

    Table 40. EMEA Vaccine Adjuvants Sales in Volume by Country (2018-2023) & (MT)

    Table 41. EMEA Vaccine Adjuvants Sales in Volume by Country (2024-2029) & (MT)

    Table 42. APAC Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. APAC Vaccine Adjuvants Sales in Value by Country (2018-2023) & (US$ Million)

    Table 44. APAC Vaccine Adjuvants Sales in Value by Country (2024-2029) & (US$ Million)

    Table 45. APAC Vaccine Adjuvants Sales in Volume by Country (2018-2023) & (MT)

    Table 46. APAC Vaccine Adjuvants Sales in Volume by Country (2024-2029) & (MT)

    Table 47. GSK Company Information

    Table 48. GSK Description and Business Overview

    Table 49. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 50. GSK Vaccine Adjuvants Product

    Table 51. GSK Recent Development

    Table 52. CSL Limited Company Information

    Table 53. CSL Limited Description and Business Overview

    Table 54. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 55. CSL Limited Vaccine Adjuvants Product

    Table 56. CSL Limited Recent Development

    Table 57. Croda Company Information

    Table 58. Croda Description and Business Overview

    Table 59. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 60. Croda Vaccine Adjuvants Product

    Table 61. Croda Recent Development

    Table 62. SEPPIC Company Information

    Table 63. SEPPIC Description and Business Overview

    Table 64. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 65. SEPPIC Vaccine Adjuvants Product

    Table 66. SEPPIC Recent Development

    Table 67. Novavax Company Information

    Table 68. Novavax Description and Business Overview

    Table 69. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 70. Novavax Vaccine Adjuvants Product

    Table 71. Novavax Recent Development

    Table 72. SPI Pharma Company Information

    Table 73. SPI Pharma Description and Business Overview

    Table 74. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 75. SPI Pharma Vaccine Adjuvants Product

    Table 76. SPI Pharma Recent Development

    Table 77. Phibro Company Information

    Table 78. Phibro Description and Business Overview

    Table 79. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 80. Phibro Vaccine Adjuvants Product

    Table 81. Phibro Recent Development

    Table 82. SDA BIO Company Information

    Table 83. SDA BIO Description and Business Overview

    Table 84. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 85. SDA BIO Vaccine Adjuvants Product

    Table 86. SDA BIO Recent Development

    Table 87. Invivogen Company Information

    Table 88. Invivogen Description and Business Overview

    Table 89. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 90. Invivogen Vaccine Adjuvants Product

    Table 91. Invivogen Recent Development

    Table 92. Tj Kaiwei Company Information

    Table 93. Tj Kaiwei Description and Business Overview

    Table 94. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 95. Tj Kaiwei Vaccine Adjuvants Product

    Table 96. Tj Kaiwei Recent Development

    Table 97. OZ Biosciences Company Information

    Table 98. OZ Biosciences Description and Business Overview

    Table 99. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 100. OZ Biosciences Vaccine Adjuvants Product

    Table 101. OZ Biosciences Recent Development

    Table 102. Brenntag Biosector Company Information

    Table 103. Brenntag Biosector Description and Business Overview

    Table 104. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 105. Brenntag Biosector Vaccine Adjuvants Product

    Table 106. Brenntag Biosector Recent Development

    Table 107. MVP Laboratories Company Information

    Table 108. MVP Laboratories Description and Business Overview

    Table 109. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 110. MVP Laboratories Vaccine Adjuvants Product

    Table 111. MVP Laboratories Recent Development

    Table 112. Zhuoyue Company Information

    Table 113. Zhuoyue Description and Business Overview

    Table 114. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 115. Zhuoyue Vaccine Adjuvants Product

    Table 116. Zhuoyue Recent Development

    Table 117. Aphios Company Information

    Table 118. Aphios Description and Business Overview

    Table 119. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

    Table 120. Aphios Vaccine Adjuvants Product

    Table 121. Aphios Recent Development

    Table 122. Key Raw Materials Lists

    Table 123. Raw Materials Key Suppliers Lists

    Table 124. Vaccine Adjuvants Customers List

    Table 125. Vaccine Adjuvants Distributors List

    Table 126. Research Programs/Design for This Report

    Table 127. Key Data Information from Secondary Sources

    Table 128. Key Data Information from Primary Sources

List of Figures

    Figure 1. Vaccine Adjuvants Product Picture

    Figure 2. Global Vaccine Adjuvants Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 3. Global Vaccine Adjuvants Market Size 2018-2029 (US$ Million)

    Figure 4. Global Vaccine Adjuvants Sales 2018-2029 (MT)

    Figure 5. India Vaccine Adjuvants Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 6. India Vaccine Adjuvants Market Size 2018-2029 (US$ Million)

    Figure 7. India Vaccine Adjuvants Sales 2018-2029 (MT)

    Figure 8. India Vaccine Adjuvants Market Share in Global, in Value (US$ Million) 2018-2029

    Figure 9. India Vaccine Adjuvants Market Share in Global, in Volume (MT) 2018-2029

    Figure 10. Vaccine Adjuvants Report Years Considered

    Figure 11. Product Picture of Aluminum Adjuvant

    Figure 12. Product Picture of Emulsions Adjuvant

    Figure 13. Product Picture of Others

    Figure 14. Global Vaccine Adjuvants Market Share by Type in 2022 & 2029

    Figure 15. Global Vaccine Adjuvants Sales in Value by Type (2018-2029) & (US$ Million)

    Figure 16. Global Vaccine Adjuvants Sales Market Share in Value by Type (2018-2029)

    Figure 17. Global Vaccine Adjuvants Sales by Type (2018-2029) & (MT)

    Figure 18. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2018-2029)

    Figure 19. Global Vaccine Adjuvants Price by Type (2018-2029) & (USD/Kg)

    Figure 20. India Vaccine Adjuvants Market Share by Type in 2022 & 2029

    Figure 21. India Vaccine Adjuvants Sales in Value by Type (2018-2029) & (US$ Million)

    Figure 22. India Vaccine Adjuvants Sales Market Share in Value by Type (2018-2029)

    Figure 23. India Vaccine Adjuvants Sales by Type (2018-2029) & (MT)

    Figure 24. India Vaccine Adjuvants Sales Market Share in Volume by Type (2018-2029)

    Figure 25. India Vaccine Adjuvants Price by Type (2018-2029) & (USD/Kg)

    Figure 26. Product Picture of Human Vaccine

    Figure 27. Product Picture of Veterinary Vaccine

    Figure 28. Global Vaccine Adjuvants Market Share by Application in 2022 & 2029

    Figure 29. Global Vaccine Adjuvants Sales in Value by Application (2018-2029) & (US$ Million)

    Figure 30. Global Vaccine Adjuvants Sales Market Share in Value by Application (2018-2029)

    Figure 31. Global Vaccine Adjuvants Sales by Application (2018-2029) & (MT)

    Figure 32. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2018-2029)

    Figure 33. Global Vaccine Adjuvants Price by Application (2018-2029) & (USD/Kg)

    Figure 34. India Vaccine Adjuvants Market Share by Application in 2022 & 2029

    Figure 35. India Vaccine Adjuvants Sales in Value by Application (2018-2029) & (US$ Million)

    Figure 36. India Vaccine Adjuvants Sales Market Share in Value by Application (2018-2029)

    Figure 37. India Vaccine Adjuvants Sales by Application (2018-2029) & (MT)

    Figure 38. India Vaccine Adjuvants Sales Market Share in Volume by Application (2018-2029)

    Figure 39. India Vaccine Adjuvants Price by Application (2018-2029) & (USD/Kg)

    Figure 40. Americas Vaccine Adjuvants Sales in Volume Growth Rate 2018-2029 (MT)

    Figure 41. Americas Vaccine Adjuvants Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 42. Americas Vaccine Adjuvants Sales by Type (2018-2029) & (MT)

    Figure 43. Americas Vaccine Adjuvants Sales Market Share in Volume by Type (2018-2029)

    Figure 44. Americas Vaccine Adjuvants Sales by Application (2018-2029) & (MT)

    Figure 45. Americas Vaccine Adjuvants Sales Market Share in Volume by Application (2018-2029)

    Figure 46. United States Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Canada Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Mexico Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Brazil Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 50. EMEA Vaccine Adjuvants Sales in Volume Growth Rate 2018-2029 (MT)

    Figure 51. EMEA Vaccine Adjuvants Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 52. EMEA Vaccine Adjuvants Sales by Type (2018-2029) & (MT)

    Figure 53. EMEA Vaccine Adjuvants Sales Market Share in Volume by Type (2018-2029)

    Figure 54. EMEA Vaccine Adjuvants Sales by Application (2018-2029) & (MT)

    Figure 55. EMEA Vaccine Adjuvants Sales Market Share in Volume by Application (2018-2029)

    Figure 56. Europe Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Middle East Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Africa Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 59. China Vaccine Adjuvants Sales in Volume Growth Rate 2018-2029 (MT)

    Figure 60. China Vaccine Adjuvants Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 61. China Vaccine Adjuvants Sales by Type (2018-2029) & (MT)

    Figure 62. China Vaccine Adjuvants Sales Market Share in Volume by Type (2018-2029)

    Figure 63. China Vaccine Adjuvants Sales by Application (2018-2029) & (MT)

    Figure 64. China Vaccine Adjuvants Sales Market Share in Volume by Application (2018-2029)

    Figure 65. APAC Vaccine Adjuvants Sales in Volume Growth Rate 2018-2029 (MT)

    Figure 66. APAC Vaccine Adjuvants Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 67. APAC Vaccine Adjuvants Sales by Type (2018-2029) & (MT)

    Figure 68. APAC Vaccine Adjuvants Sales Market Share in Volume by Type (2018-2029)

    Figure 69. APAC Vaccine Adjuvants Sales by Application (2018-2029) & (MT)

    Figure 70. APAC Vaccine Adjuvants Sales Market Share in Volume by Application (2018-2029)

    Figure 71. Japan Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 72. South Korea Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 73. China Taiwan Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 74. Southeast Asia Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 75. India Vaccine Adjuvants Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 76. Vaccine Adjuvants Value Chain

    Figure 77. Vaccine Adjuvants Production Process

    Figure 78. Channels of Distribution

    Figure 79. Distributors Profiles

    Figure 80. Bottom-up and Top-down Approaches for This Report

    Figure 81. Data Triangulation

    Figure 82. Key Executives Interviewed